GenScript USA Inc.

GenScript USA Inc. is a leading biotechnology company that specializes in gene synthesis, peptide synthesis, and antibody development. Established with the vision of accelerating life science research, GenScript provides innovative solutions to researchers and pharmaceutical companies worldwide.

The company’s core activities include:

• Gene Synthesis: Offering high-quality, custom gene synthesis services that enable researchers to create genes for various applications.
• Peptide Synthesis: Providing tailored peptide synthesis services that support drug discovery and development.
• Antibody Development: Specializing in monoclonal and polyclonal antibody production to aid in diagnostics and therapeutics.

With a commitment to quality and customer satisfaction, GenScript employs advanced technologies and a team of experienced scientists to ensure the highest standards in all its products and services. The company also invests heavily in research and development to stay at the forefront of biotechnological advancements.

GenScript’s mission is to empower researchers by providing them with the tools they need to make groundbreaking discoveries. By fostering collaboration and innovation, the company aims to contribute significantly to the global life sciences community.

Headquartered in the UK, GenScript operates globally, serving a diverse clientele that includes academic institutions, biotech firms, and pharmaceutical companies. The company’s dedication to excellence and its comprehensive range of services make it a trusted partner in the field of biotechnology.